Cargando…

INTENSIVE CIRCUIT CLASS THERAPY IN PATIENTS WITH RELAPSING-REMITTING MULTIPLE SCLEROSIS

OBJECTIVE: Long-term physiotherapy is of considerable benefit to patients with multiple sclerosis (MS) who have motor dysfunction or gait impairment. The aim of this study was to determine the effectiveness of a 12-week intensive circuit class therapy for patients with MS, with a wider focus on fati...

Descripción completa

Detalles Bibliográficos
Autores principales: KOCICA, Jan, KOLCAVA, Jan, SLADECKOVA, Michaela, STOURAC, Pavel, VLCKOVA, Eva, DOSBABA, Filip, KRATOCHVILOVA, Jitka, BEDNARIK, Josef
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medical Journals Sweden AB 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8963414/
https://www.ncbi.nlm.nih.gov/pubmed/35174869
http://dx.doi.org/10.2340/jrm.v54.2027
_version_ 1784677985594376192
author KOCICA, Jan
KOLCAVA, Jan
SLADECKOVA, Michaela
STOURAC, Pavel
VLCKOVA, Eva
DOSBABA, Filip
KRATOCHVILOVA, Jitka
BEDNARIK, Josef
author_facet KOCICA, Jan
KOLCAVA, Jan
SLADECKOVA, Michaela
STOURAC, Pavel
VLCKOVA, Eva
DOSBABA, Filip
KRATOCHVILOVA, Jitka
BEDNARIK, Josef
author_sort KOCICA, Jan
collection PubMed
description OBJECTIVE: Long-term physiotherapy is of considerable benefit to patients with multiple sclerosis (MS) who have motor dysfunction or gait impairment. The aim of this study was to determine the effectiveness of a 12-week intensive circuit class therapy for patients with MS, with a wider focus on fatigue and gait ability. METHODS: A total of 46 patients with relapsing-remitting MS were divided randomly into 2 groups: 23 patients (mean Expanded Disability Status Scale (EDSS) 2.33 ± 0.74) participated in an intensive 12-week course of intensive circuit class therapy, and 23 patients (mean EDSS 2.04 ± 0.63) served as a control group. The EDSS, Timed Up and Go (TUG) test and Four-Stage Balance Test (FSBT) made up the physical testing part, supplemented by questionnaires such as the Modified Fatigue Impact Scale (MFIS), 12-Item Multiple Sclerosis Walking Scale (MSWS-12), Beck Depression Inventory (BDI) and 36-Item Short Form Survey (SF-36). RESULTS: Significant improvements were found among intensive circuit class therapy-exercising patients in FSBT (p < 0.05), TUG test (p < 0.01), MFIS (p < 0.01), BDI (p < 0.05), MSWS-12 (p < 0.05) and the 3 subscales of SF-36 after 12 weeks of intensive circuit class therapy, while there were no significant changes in the control group. CONCLUSION: Intensive circuit class therapy is an effective therapeutic approach for improving gait and balance problems in patients with MS. It has also proved to alleviate fatigue and symptoms of depression.
format Online
Article
Text
id pubmed-8963414
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Medical Journals Sweden AB
record_format MEDLINE/PubMed
spelling pubmed-89634142022-03-31 INTENSIVE CIRCUIT CLASS THERAPY IN PATIENTS WITH RELAPSING-REMITTING MULTIPLE SCLEROSIS KOCICA, Jan KOLCAVA, Jan SLADECKOVA, Michaela STOURAC, Pavel VLCKOVA, Eva DOSBABA, Filip KRATOCHVILOVA, Jitka BEDNARIK, Josef J Rehabil Med Original Report OBJECTIVE: Long-term physiotherapy is of considerable benefit to patients with multiple sclerosis (MS) who have motor dysfunction or gait impairment. The aim of this study was to determine the effectiveness of a 12-week intensive circuit class therapy for patients with MS, with a wider focus on fatigue and gait ability. METHODS: A total of 46 patients with relapsing-remitting MS were divided randomly into 2 groups: 23 patients (mean Expanded Disability Status Scale (EDSS) 2.33 ± 0.74) participated in an intensive 12-week course of intensive circuit class therapy, and 23 patients (mean EDSS 2.04 ± 0.63) served as a control group. The EDSS, Timed Up and Go (TUG) test and Four-Stage Balance Test (FSBT) made up the physical testing part, supplemented by questionnaires such as the Modified Fatigue Impact Scale (MFIS), 12-Item Multiple Sclerosis Walking Scale (MSWS-12), Beck Depression Inventory (BDI) and 36-Item Short Form Survey (SF-36). RESULTS: Significant improvements were found among intensive circuit class therapy-exercising patients in FSBT (p < 0.05), TUG test (p < 0.01), MFIS (p < 0.01), BDI (p < 0.05), MSWS-12 (p < 0.05) and the 3 subscales of SF-36 after 12 weeks of intensive circuit class therapy, while there were no significant changes in the control group. CONCLUSION: Intensive circuit class therapy is an effective therapeutic approach for improving gait and balance problems in patients with MS. It has also proved to alleviate fatigue and symptoms of depression. Medical Journals Sweden AB 2022-03-29 /pmc/articles/PMC8963414/ /pubmed/35174869 http://dx.doi.org/10.2340/jrm.v54.2027 Text en © Published by Medical Journals Sweden, on behalf of the Foundation for Rehabilitation Information https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (https://creativecommons.org/licenses/by-nc/4.0/)
spellingShingle Original Report
KOCICA, Jan
KOLCAVA, Jan
SLADECKOVA, Michaela
STOURAC, Pavel
VLCKOVA, Eva
DOSBABA, Filip
KRATOCHVILOVA, Jitka
BEDNARIK, Josef
INTENSIVE CIRCUIT CLASS THERAPY IN PATIENTS WITH RELAPSING-REMITTING MULTIPLE SCLEROSIS
title INTENSIVE CIRCUIT CLASS THERAPY IN PATIENTS WITH RELAPSING-REMITTING MULTIPLE SCLEROSIS
title_full INTENSIVE CIRCUIT CLASS THERAPY IN PATIENTS WITH RELAPSING-REMITTING MULTIPLE SCLEROSIS
title_fullStr INTENSIVE CIRCUIT CLASS THERAPY IN PATIENTS WITH RELAPSING-REMITTING MULTIPLE SCLEROSIS
title_full_unstemmed INTENSIVE CIRCUIT CLASS THERAPY IN PATIENTS WITH RELAPSING-REMITTING MULTIPLE SCLEROSIS
title_short INTENSIVE CIRCUIT CLASS THERAPY IN PATIENTS WITH RELAPSING-REMITTING MULTIPLE SCLEROSIS
title_sort intensive circuit class therapy in patients with relapsing-remitting multiple sclerosis
topic Original Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8963414/
https://www.ncbi.nlm.nih.gov/pubmed/35174869
http://dx.doi.org/10.2340/jrm.v54.2027
work_keys_str_mv AT kocicajan intensivecircuitclasstherapyinpatientswithrelapsingremittingmultiplesclerosis
AT kolcavajan intensivecircuitclasstherapyinpatientswithrelapsingremittingmultiplesclerosis
AT sladeckovamichaela intensivecircuitclasstherapyinpatientswithrelapsingremittingmultiplesclerosis
AT stouracpavel intensivecircuitclasstherapyinpatientswithrelapsingremittingmultiplesclerosis
AT vlckovaeva intensivecircuitclasstherapyinpatientswithrelapsingremittingmultiplesclerosis
AT dosbabafilip intensivecircuitclasstherapyinpatientswithrelapsingremittingmultiplesclerosis
AT kratochvilovajitka intensivecircuitclasstherapyinpatientswithrelapsingremittingmultiplesclerosis
AT bednarikjosef intensivecircuitclasstherapyinpatientswithrelapsingremittingmultiplesclerosis